| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 05/01/2003 | US20030083490 Coupling of H-phosphonate with a nucleoside alcohol to form the diester; oxidation with sulfur transfer agent to form a phosphorothioate triester |
| 05/01/2003 | US20030083364 3-Substituted-3-(substitutedsulfonyl or sulfanyl)pyrroldine-2,5-diones useful for inhibition of farnesyl-protein transferase |
| 05/01/2003 | US20030083349 Antimalaria agents |
| 05/01/2003 | US20030083348 Farnesyl transferase inhibitors |
| 05/01/2003 | US20030083337 Optically active 3-[(2-piperazinylphenyl)methyl]-1-[4-(trifluoromethyl)phenyl]-2-pyrrolidinone compounds as 5-HT1D receptor selective antagonists |
| 05/01/2003 | US20030083331 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
| 05/01/2003 | US20030083268 Isoquinoline compounds having antiinfective activity |
| 05/01/2003 | US20030083228 Treatments for female sexual dysfunction and methods for identifying compounds useful for treating female sexual dysfunction |
| 05/01/2003 | US20030082225 Sterile, breathable patch for treating wound pain |
| 05/01/2003 | US20030080320 Combining a tertiary amide with a pentavalent phosphorous halide in a solvent to form an alpha - haloiminium salt and converting the alpha -haloiminium salt to the alpha -haloenamine with a base |
| 05/01/2003 | CA2464254A1 Inhibitors of post-proline cleaving proteases |
| 05/01/2003 | CA2463309A1 Sterile, breathable patch for treating wound pain |
| 04/30/2003 | CN1414950A Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 04/30/2003 | CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof |
| 04/30/2003 | CN1107067C Carbapenem compounds, use and intermediate compounds thereof |
| 04/30/2003 | CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists |
| 04/29/2003 | US6555714 P-hydrophenylpyruvate dioxygenases (HPPD) from plants is incubated with test substrate and enzymatic activity of enzyme is determined in comparison with activity of uninhibited enzyme |
| 04/29/2003 | US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery |
| 04/29/2003 | US6555694 Method for production of pyrrolidinone derivatives |
| 04/29/2003 | US6555692 Polylactams having imidazole or pyrrole rings specifically bind with subnanomolar affinity to a predetermined DNA sequence; use in molecular biology and diagnostic medicine; gene expression control; target the minor groove of B-form |
| 04/29/2003 | US6555572 Benzylated PDE4 inhibitors |
| 04/29/2003 | US6555556 N-(4-(1-acetimidoylpiperidin-4-yl)oxyphenyl)-N-((E)-3-(3 -amidinophenyl)-2-methyl-2-propenyl)sulfamoylacetic acid dihydrochloride for example; factor Xa inhibitors |
| 04/29/2003 | US6555541 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
| 04/29/2003 | CA2083980C Aminoalkylpyrrolidinylthiocarbapenem derivatives |
| 04/24/2003 | WO2003033484A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/24/2003 | WO2003032981A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032910A2 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | WO2002098850A3 Chemical compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 04/24/2003 | US20030078444 Fluorous triphase and ther multiphase systems for effecting reactions and/or separation |
| 04/24/2003 | US20030078438 N-heterocyclicamide compounds; used as anticoagulant agent |
| 04/24/2003 | US20030078420 New derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 04/24/2003 | US20030078339 Degradable cross-linking agents and cross-linked network polymers formed therewith |
| 04/24/2003 | US20030078302 As carriers for delivering active agents such as peptides, drugs by administration, such as oral, subcutaneous, sublingual, and intranasal administration |
| 04/24/2003 | US20030078286 For therapy of central nervous system disorders such as anxiety, depression, motor disorders |
| 04/24/2003 | US20030078261 Prostaglandin agonists |
| 04/24/2003 | US20030078253 Matrix metalloprotease inhibitors |
| 04/24/2003 | US20030078249 VLA-4 inhibitor compounds |
| 04/24/2003 | US20030078247 Enzyme inhibitor of a dipeptidyl peptidase for treating hyperglycaemia |
| 04/24/2003 | US20030078241 Treating effects of excessive reactive oxygen species |
| 04/24/2003 | CA2463518A1 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | CA2463469A1 4-(4-alkoxy-3-hydroxyphenyl)-2-pyrrolidone derivatives as pde-4 inhibitors for the treatment of neurological syndromes |
| 04/24/2003 | CA2463426A1 Substituted piperazine cyclohexane carboxilic acid amides and the use thereof |
| 04/23/2003 | EP1304327A2 Glutamine-thiazolidide and -pyrrolidide and their use as dipeptidylpeptidase IV inhibitors |
| 04/23/2003 | EP1304323A1 Preventives or remedies for atopic dermatitis |
| 04/23/2003 | EP1303509A1 Beta3 adrenergic agonists |
| 04/23/2003 | EP1303503A2 Aniline derivatives |
| 04/23/2003 | EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 04/23/2003 | EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2003 | EP1303307A2 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents |
| 04/23/2003 | EP1102739B1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 04/23/2003 | EP1082314B1 New dipeptidyl peptidase iv effectors |
| 04/23/2003 | EP1063230B1 Cyclic amino compounds |
| 04/23/2003 | EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels |
| 04/23/2003 | EP1007032B1 4-cyano-4-deformylsordaricin derivatives |
| 04/23/2003 | EP0993442B1 Hydrazine derivatives |
| 04/23/2003 | EP0937041B1 Use of a pharmaceutically acceptable salt of (3R,2'R)-3-[(Cyclopently-hydroxyphenylacetyl)oxy]-1,1-dimethyl-pyrrolidinium for the preparation of a medicament |
| 04/23/2003 | EP0915846B1 2- and 2,5-substituted phenylketoenols |
| 04/23/2003 | EP0836615B1 New thrombin inhibitors, their preparation and use |
| 04/23/2003 | CN1413217A Olefin polymerization cocatalysts derived from group-15 compounds and process using them |
| 04/23/2003 | CN1413207A 5-membered ring heterocyclic compounds with nitrogen |
| 04/23/2003 | CN1413193A Nitrile derivatives as cathepsin K inhibitors |
| 04/23/2003 | CN1413191A Method for production of N-alkenyl amides |
| 04/23/2003 | CN1413190A EP4 receptor selective agonists in treatment of osteoporosis |
| 04/23/2003 | CN1413189A Benzamidine derivatives |
| 04/23/2003 | CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 04/23/2003 | CN1106380C New synthetic catechol derivatives, method for production and use thereof |
| 04/22/2003 | US6552225 Such as n-(2,3-dichloro-4-(methylaminosulphonyl)phenyl)-3,3,3-trifluoro-2-hydroxy-2 -methylpropanamide; diabetes, obesity, lactic acidaemia |
| 04/22/2003 | US6552216 Molecular model for VLA-4 inhibitors |
| 04/22/2003 | US6552090 Perfluoroalkyl haloalkyl ethers and compositions and applications thereof |
| 04/22/2003 | US6552067 EP4 receptor selective agonists in the treatment of osteoporosis |
| 04/22/2003 | US6552061 Amino acid derivatives and anti-inflammatory agents |
| 04/22/2003 | US6552051 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation |
| 04/22/2003 | US6552041 Cyclized amide derivatives useful for treating or preventing neuronal damage associated with neurological disease |
| 04/22/2003 | US6552038 Anticoagulant agents |
| 04/22/2003 | US6552022 Atherosclerosis in a mammal, pancreatitis, non-insulin dependent diabetes mellitus, coronary heart disease in a lowering serum lipid levels |
| 04/17/2003 | WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | WO2003031414A1 Novel heterocyclic compound and anti-inflammatory agent |
| 04/17/2003 | WO2003030900A1 Remedies for attention-deficient/hyperreactivity disorder |
| 04/17/2003 | WO2003030899A2 Use of 2-oxo-1-pyrrolidine derivatives for the treatment of dyskinesia and movement disorders |
| 04/17/2003 | WO2003030897A1 Pyrrolidinone derivatives |
| 04/17/2003 | WO2003030889A1 Para-amino benzoic acids as integrin antagonists |
| 04/17/2003 | WO2003030886A2 Allylamides useful in the treatment of alzheimer's disease |
| 04/17/2003 | WO2003013484A3 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 04/17/2003 | WO2003006454A3 Heterocyclic carboxamides and their use as fungicides |
| 04/17/2003 | WO2002036641A3 Improved productivity catalysts and microstructure control |
| 04/17/2003 | WO2001053275A3 Substituted aryl ketones |
| 04/17/2003 | WO2000037430A3 Use of androgen receptor suppressors |
| 04/17/2003 | US20030073851 Arylphenyl-substituted cyclic ketoenols |
| 04/17/2003 | US20030073845 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors |
| 04/17/2003 | US20030073836 Heteroarylcarboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 04/17/2003 | US20030073832 Novel aminophenyl ketone derivatives |
| 04/17/2003 | US20030073731 Alkylation therapy; anticancer agent |
| 04/17/2003 | US20030073682 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 04/17/2003 | US20030070241 Substituted 2-aminoalkyl-1,4-Diaminobenzene compounds and oxidation dye precursor compositions containing same |
| 04/17/2003 | CA2463198A1 Pyrrolidinone derivatives |
| 04/17/2003 | CA2462875A1 Allylamides useful in the treatment of alzheimer's disease |
| 04/17/2003 | CA2462862A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | CA2462301A1 Para-amino benzoic acids as integrin antagonists |